Abstract:Tumors pose a significant threat to human health, and their occurrence and fatality rates are on the rise each year. Accurate tumor diagnosis is crucial in preventing untimely treatment and late-stage metastasis, thereby reducing mortality. To address this, we have developed a novel type of hybrid nanogels called γ-Fe2O3@PNIPAM/PAm/CTS, which contain iron oxide nanoparticles and poly(N-isopropyl acrylamide)/poly(acrylamide)/chitosan. The rational for this study relies on the concept that thermosensitive PNIPAM has the ability to contract when exposed to the elevated temperature conditions found within tumors. This contraction leads to a dense clustering of the high-loading γ-Fe2O3 nanoparticles within the nanogel, thus greatly enhancing the capabilities of MRI imaging. Additionally, the amino groups in chitosan on the particle surface can be converted into ammonium salts under mildly acidic conditions, allowing for an increase in the charge of the nanogel specifically at the slightly acidic tumor site. Consequently, it promotes the phagocytosis of tumor cells and effectively enhances the accumulation and retention of nanogels at the tumor site. The synthesis of the hybrid nanogels involves a surfactant-free emulsion copolymerization process, where vinyl-modified γ-Fe2O3 superparamagnetic nanoparticles are copolymerized with the monomers in the presence of chitosan. We have optimized various reaction parameters to achieve a high loading content of the superparamagnetic nanoparticles, reaching up to 60%. The achieved r2 value of 517.74 mM-1S-1 significantly surpasses that of the clinical imaging contrast agent Resovist (approximately 151 mM-1S-1). To assess the performance of these magnetic nanogels, we conducted experiments using Cal27 oral tumors and 4T1 breast tumors in animal models. The nanogels exhibited temperature- and pH-sensitivity, enabling magnetic targeting and enhancing diagnosis through MRI imaging. The results demonstrated the potential of these hybrid nanogels as contrast agents for magnetic targeting in biomedical applications.

Extremely Small Iron Oxide Nanoparticle-Encapsulated Nanogels As a Glutathione-Responsive T1 Contrast Agent for Tumor-Targeted Magnetic Resonance Imaging

Magnetic Resonance Imaging Contrast Agent: Crgd-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor

Redox-Triggered Aggregation of ESIONPs with T1 to T2 Switchable Contrasting Effect for Magnetic Resonance Imaging

Construction of cRGD-iron oxide nanoparticles and its application in the tumor diagnosis by magnetic resonance imaging

Redox-triggered Aggregation of ESIONPs with Switchable T1 to T2 Contrast Effect for T2-weighted Magnetic Resonance Imaging.

Extremely Small Iron Oxide Nanoparticles with Ph-Dependent Solubility Transition As T1/T2 Switchable Contrast Agents for MRI

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Fabrication and Evaluation of Tumor-Targeted Positive MRI Contrast Agent Based on Ultrasmall MnO Nanoparticles.

Gadolinium-based contrast agents for tumor targeting imaging

Tumor Acid Microenvironment-Triggered Self-Assembly of ESIONPs for T1/T2 Switchable Magnetic Resonance Imaging

Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of Tumors

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Hypoxia-Responsive Aggregation of Iron Oxide Nanoparticles for T1-to-T2 Switchable Magnetic Resonance Imaging of Tumors

Enhancing MRI imaging through high loading of superparamagnetic nanogels with high sensitivity to the tumor environment

Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents

Enhanced Tumor Imaging Using Glucosamine-Conjugated Polyacrylic Acid-Coated Ultrasmall Gadolinium Oxide Nanoparticles in Magnetic Resonance Imaging

Iron oxide nanoclusters formed by acid-induced in situ calcium ion cross-linking for targeted magnetic resonance imaging of glioblastoma

Long-Lasting and Efficient Tumor Imaging Using a High Relaxivity Polysaccharide Nanogel Magnetic Resonance Imaging Contrast Agent

Ultrasmall bimodal Nanomolecules enhanced tumor angiogenesis contrast with endothelial cell targeting and molecular pharmacokinetics.

Facile Synthesis of Ultra-Small Hollow Manganese Silicate Nanoparticles As Ph/gsh-Responsive T1-MRI Contrast Agents

A Tumor-Targeting and ROS-responsive Iron-Based T1 Magnetic Resonance Imaging Contrast Agent for Highly Specific Tumor Imaging.